“Our work is the presentation of our capabilities." — Edward Gibbon
- A 5-minute COVID test
- The math behind health interventions
- Virtual field trips
- Aerosol science
- $2M from NIH for cytokine storm treatment
- A diabetes drug for COVID-19 treatment?
- Podcast: Innovation frontiers around the globe
- 2021 Future of Work Summit
- PUDDLE HOPS: Health tech
March 31, 2021
RESEARCH & PANDEMIC INNOVATION
Mathematician explores COVID-19 health interventions
University of Kansas mathematician Folashade Agusto is doing COVID-19 research around the public perception of risk, local case rates, behavior of neighboring communities, popularity of public health policies, and media reporting to demonstrate the effectiveness of different public health interventions.
School field trips are not an easy thing under the best of circumstances, but COVID-19 really threw a monkey wrench into the time-honored events that are integral to the learning process. The Juda School District in Wisconsin has connected with UW-Madison to offer kids virtual field trips.
COVID and aerosol science
Reseachers at the McKelvey School of Engineering are putting their expertise in aerosol science to work to learn more about COVID-19. You can read about some of their research here.
NIH funds further research on GP1681
CytoAgents, a Pittsburgh-based pharmaceutical company responsible for the drug candidate GP1681, has received $2M in grant money from the NIH to further its studies. GP1681 treats cytokine storm, which is associated with immunotherapy, and advanced CAR T-cell therapy.
Studying the effectiveness of diabetes drug for COVID-19
A new multi-site clinical trial led by the University of Minnesota Medical School is studying the effectiveness of metformin, a generic medication for type 2 diabetes, in the treatment of COVID-19.
Innovation frontiers around the globe
If you enjoy discovering innovation in surprising places and hearing stories from entrepreneurial leaders, Fast Frontiers is your new must-listen to podcast. Host Tim Schigel, Managing Partner of Refinery Ventures, brings you interviews from leading funders, ecosystem builders, corporate innovators, and startup founders.
How ambition & community fueled Australia’s tech scene — S2:E10
There is a thriving technology ecosystem in Australia. Hear how ambition and community played a key role in its development. Niki Scevak, co-founder and partner of Blackbird Ventures in Melbourne, joins Fast Frontiers to explain.
Boomerang lessons for entrepreneurs — S2:E11
From Cleveland to the West Coast and back to Cleveland and from big company to startup, Steven Santamaria, former Intel leader and now CEO of Folio Photonics, shares insight about his transition and keys to success for entrepreneurs including how to leverage and maximize contributions from your board.
Learn lessons from Startup Nation Israel - not to be afraid to fail, take risks reasonably, and ultimately be mission-driven, and just get stuff done. Jon Medved, founder and CEO of OurCrowd in Israel, joins Fast Frontiers podcast to explain and share his insight into tech investing.
Flyover Future has followed medical and tech news around COVID-19 from the beginning of the pandemic. We're adding coverage to this report related to health care innovation to feature more advances across Flyover Country.
- Minnesota-based Inspire Medical Systems, Inc., has gotten FDA approval for a surgical implant procedure for obstructive sleep apnea.
Share stories, offer suggestions, or comment!